Cargando…

Immune checkpoint inhibitors: friend or foe for osteoporosis

Detalles Bibliográficos
Autor principal:	Tang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983083/ https://www.ncbi.nlm.nih.gov/pubmed/36876151 http://dx.doi.org/10.1177/20420188231157194

Ejemplares similares

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

CytoSorb-friend or foe!!
por: Pattnaik, Saroj Kumar, et al.
Publicado: (2015)

Perioperative metformin: Friend or foe
por: Nair, Abhijit S.
Publicado: (2020)

Obesity: Friend or foe for osteoporosis
por: Sharma, Sudhaa, et al.
Publicado: (2014)

Testosterone in COVID-19: Friend or Foe?
por: Niemann, Peter J., et al.
Publicado: (2021)

Estrogen and COVID-19: friend or foe?
por: Di Vincenzo, A., et al.
Publicado: (2021)

Breast Implant Capsule: Friend, Not Foe
por: Frojo, Gianfranco, et al.
Publicado: (2022)

Azithromycin in patients with COVID-19: Friend or foe?
por: Kow, Chia Siang, et al.
Publicado: (2021)

Friend turned foe: E-cadherin perversely protects micrometastases
por: Wells, Alan, et al.
Publicado: (2017)

Vitamin D supplementation in COVID-19: A friend or foe?
por: Mansour, Asieh, et al.
Publicado: (2020)

Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
por: Franzese, Ornella, et al.
Publicado: (2022)

Routine Change of Nasogastric Tube in Intensive Care Unit: Friend or Foe
por: Zand, F, et al.
Publicado: (2011)

TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?
por: Benoot, Thomas, et al.
Publicado: (2021)

Internal thoracic vein: friend or foe?
por: Roubelakis, A, et al.
Publicado: (2014)

Gastric lavage in hair dye (Super-Vasmaol 33) poisoning: A friend or foe
por: Shaik, Nawaz Ahmed, et al.
Publicado: (2012)

The angiogenic factors and their soluble receptors in sepsis: friend, foe, or both?
por: Zhang, Ru-Yuan, et al.
Publicado: (2013)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Friendly foes: The evolution of host protection by a parasite
por: Ashby, Ben, et al.
Publicado: (2017)

Innate immunity and HPV: friends or foes
por: Nunes, Rafaella Almeida Lima, et al.
Publicado: (2018)

MDR1 in immunity: friend or foe?
por: Bossennec, Marion, et al.
Publicado: (2018)

Friend and Foe
Publicado: (1890)

PARP Inhibitors and Haematological Malignancies—Friend or Foe?
por: Skelding, Kathryn A., et al.
Publicado: (2021)

Microcirculation and mean arterial pressure: friends or foes?—reply
por: Kazune, Sigita, et al.
Publicado: (2020)

Innate Immunity and Biomaterials at the Nexus: Friends or Foes
por: Christo, Susan N., et al.
Publicado: (2015)

The immune system in cancer metastasis: friend or foe?
por: Janssen, Louise M.E., et al.
Publicado: (2017)

The Hippo pathway and cancer immunity: friend or foe?
por: Janse van Rensburg, Helena J, et al.
Publicado: (2018)

Exosomes and Immune Response in Cancer: Friends or Foes?
por: Barros, Francisco M., et al.
Publicado: (2018)

Immune System, Friend or Foe of Oncolytic Virotherapy?
por: Filley, Anna C., et al.
Publicado: (2017)

Oncogene addiction and immune escape: friends or foes?
por: Abdayem, Pamela, et al.
Publicado: (2020)

The immune system and COVID-19: Friend or foe?
por: Yazdanpanah, Fereshteh, et al.
Publicado: (2020)

The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
por: Lopes, Raquel, et al.
Publicado: (2021)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

Fibroblasts in cancer dormancy: foe or friend?
por: Dai, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e8la4vjb959l97dt2nc6np8g5u